Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Liver fibrosis occurs as a wound-healing response to chronic hepatic injuries irrespective of the underlying etiology and may progress to life-threatening cirrhosis. Here we show that CCN1, a matricellular protein of the CCN (CYR61/CTGF/NOV) family, is accumulated in hepatocytes of human cirrhotic livers. CCN1 is not required for liver development or regeneration, since these processes are normal in mice with hepatocyte-specific Ccn1 deletion. However, Ccn1 expression is upregulated upon liver injuries and functions to inhibit liver fibrogenesis induced by either carbon tetrachloride intoxication or bile duct ligation and promote fibrosis regression. CCN1 acts by triggering cellular senescence in activated hepatic stellate cells and portal fibroblasts by engaging integrin α6β1 to induce reactive oxygen species accumulation through the RAC1-NADPH oxidase 1 enzyme complex, whereupon the senescent cells express an antifibrosis genetic program. Mice with hepatocyte-specific Ccn1 deletion suffer exacerbated fibrosis with a concomitant deficit in cellular senescence, whereas overexpression of hepatic Ccn1 reduces liver fibrosis with enhanced senescence. Furthermore, tail vein delivery of purified CCN1 protein accelerates fibrosis regression in mice with established fibrosis. These findings reveal a novel integrin-dependent mechanism of fibrosis resolution in chronic liver injury and identify the CCN1 signaling pathway as a potential target for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“activation of the matricellular protein CCN1 was shown to induce senescence during skin and liver repair (Jun and Lau, 2010; Kim et al., 2013).”
From An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA (2014) · cites this paper as Kim et al., 2013
In the citing paper
“Cellular senescence contributes to the maintenance of the structure and the function of tissues following injury.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [146]
In the citing paper
“in liver fibrosis, a condition associated with scarring of the liver and decrease in its function, senescence limits the proliferation and expansion of ECM-producing activated hepatic stellate cells145,146. This response limits the progression of the pathology following liver damage.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [146]
In the citing paper
“and accelerate fibrosis resolution in chronic inflammatory injuries by inducing senescence in myofibroblasts through integrin α6β1. [ 12 , 16 ]”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [16]
In the citing paper
“In the liver, CCN1 can promote biliary regeneration after cholestasis by inducing cholangiocyte proliferation”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [16]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“Cellular senescence is a form of irreversible cell cycle arrest that occurs in response to cellular stresses such as DNA damage, oxidative stress, oncogene activation, chromatin disruption, and telomere erosion (47, 48).”
BackgroundFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“Whereas senescence is a well-recognized mechanism of tumor suppression, emerging evidence indicates that it may play a role in aging, tissue repair, and even malignancy (12).”
BackgroundSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 5×
“Although a previous report (11) has suggested that senescence can limit fibrosis, this emerging concept has been tested only in CCl4-induced injury in the liver.”
BackgroundInfluentialPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727 · cited 1×
“using a hydrodynamic delivery method (23).”
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 2×
“Cellular senescence is a form of irreversible cell cycle arrest that occurs in response to cellular stresses such as DNA damage, oxidative stress, oncogene activation, chromatin disruption, and telomere erosion (47, 48).”
BackgroundDebacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
Research works printed but not linked: 3
- Constandinou C, 2005, Methods Mol. Med., 117, 237
- Kountouras J, 1984, Br. J. Exp. Pathol., 65, 305
- Weiskirchen R, 2005, Methods Mol. Med., 117, 99
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
“The upstream signals that induce senescence after wounding are not yet known, although activation of the matricellular protein CCN1 was shown to induce senescence during skin and liver repair (Jun and Lau, 2010; Kim et al., 2013).”
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
“ROS accumulation through Rac1-NADPH oxidase 1 enzyme complex in HSCs [142].”
BackgroundCellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Mice treated with recombinant CCN1, IL-22, or IGF-1 displayed accelerated fibrotic resolution (182, 186, 245), suggesting that prosenescence therapies could be promising agents to resolve liver fibrosis.”
BackgroundSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
“Senescence is associated with liver fibrosis (Kim et al., 2013) and cirrhosis (Wiemann et al.”
BackgroundHippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Inside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Musso, G., Cassader, M., & Gambino, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.3 · Cited by 412
Biomarkers of cellular senescence and skin aging
Wang, A. S., & Dreesen, O. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00247 · Cited by 404
Adverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
“2016), senescence of activated stellate cells which results in a phenotype with reduced fibrogenic activity and increased sensitivity to killing by immune cells (Krizhanovsky et al. 2008; Kim et al. 2013), as well as reversal of activated, collagen-producing stellate cells to a quiescent state (Kisseleva et al.”
BackgroundJun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 345
Self-citationCellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345
Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293
“Upon liver damage, for example, hepatic stellate cells (HSCs) differentiate into activated myofibroblasts that extensively proliferate and secrete extracellular matrix (ECM).”
InfluentialCellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., & Marra, F. (2021) · Cells · doi:10.3390/cells10102759 · Cited by 270
“A variety of proteins, such as the matricellular protein CCN1/CYR61 [74], insulin-like growth factor I (IGF-I) and interleukin (IL)-10, IL-22 have been identified as inducers of senescence in aHSCs.”
BackgroundThe wound healing, chronic fibrosis, and cancer progression triad
Rybinski, B., Franco-Barraza, J., & Cukierman, E. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00158.2013 · Cited by 253
Physiological and pathological consequences of cellular senescence
Burton, D. G. A., & Krizhanovsky, V. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1691-3 · Cited by 253
“In mice lacking molecular components required for induction of cell senescence, HSCs continue to proliferate, depositing ECM components and elevating the fibrotic response [53].”
BackgroundInfluentialClassical and Nonclassical Intercellular Communication in Senescence and Ageing
Fafián-Labora, J. A., & O’Loghlen, A. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.05.003 · Cited by 228
The ECM path of senescence in aging: components and modifiers
Levi, N., Papismadov, N., Solomonov, I., Sagi, I., & Krizhanovsky, V. (2020) · The FEBS Journal · doi:10.1111/febs.15282 · Cited by 219
Li, F., Huangyang, P., Burrows, M., Guo, K., Riscal, R., Godfrey, J., Lee, K. E., Lin, N., Lee, P., Blair, I. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0511-2 · Cited by 209
Extracellular Matrix and Liver Disease
Arriazu, E., Ruiz de Galarreta, M., Cubero, F. J., Varela-Rey, M., Pérez de Obanos, M. P., Leung, T. M., Lopategi, A., Benedicto, A., Abraham-Enachescu, I., & Nieto, N. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5697 · Cited by 193
“The authors suggest that an increase in ROS could lead to DNA damage and, thus, activate the p53 and p16 pathway to induce senescence (70) (Fig.”
Proteostasis in cardiac health and disease
Henning, R. H., & Brundel, B. J. J. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.89 · Cited by 193
The role of growth hormone and insulin-like growth factor-I in the liver
Takahashi, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071447 · Cited by 193
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
“In the resolution stage of liver fibrosis, they are able to undergo (1) apoptosis by Fas (clusters of differentiation [CD]95), tumor necrosis factor (TNF) receptor 1, p75(neurotrophin receptor; p75NTR), and tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) receptors by combining with their ligands(27); (…”
BackgroundAutophagy drives fibroblast senescence through MTORC2 regulation
Bernard, M., Yang, B., Migneault, F., Turgeon, J., Dieudé, M., Olivier, M.-A., Cardin, G. B., El-Diwany, M., Underwood, K., Rodier, F., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1713640 · Cited by 173
“These results are in line with the study showing that mice with ccn1 (cellular communication network factor 1)-null hepatocytes have non-senescent hepatic stellate cells (HSC) and increased fibrotic response [10].”
BackgroundResultCarloni, V., Luong, T. V., & Rombouts, K. (2014) · Liver International · doi:10.1111/liv.12465 · Cited by 173
“In this way, and by engaging integrin alpha6beta1, several reactive oxygen species are formed thereby inducing an antifibrotic gene expression (97).”
BackgroundCellular senescence in the aging and diseased kidney
Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0434-2 · Cited by 173
The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing
Jun, J.-I., Kim, K.-H., & Lau, L. F. (2015) · Nature Communications · doi:10.1038/ncomms8386 · Cited by 173
Self-citationKubota, S., & Takigawa, M. (2015) · Clinical Science · doi:10.1042/cs20140264 · Cited by 166
Reversal of liver fibrosis: From fiction to reality
Zoubek, M. E., Trautwein, C., & Strnad, P. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.04.005 · Cited by 174
Liver Fibrosis: From Pathogenesis to Novel Therapies
Weiskirchen, R., & Tacke, F. (2016) · Digestive Diseases · doi:10.1159/000444556 · Cited by 156
β-Hydroxybutyrate Prevents Vascular Senescence through hnRNP A1-Mediated Upregulation of Oct4
Han, Y.-M., Bedarida, T., Ding, Y., Somba, B. K., Lu, Q., Wang, Q., Song, P., & Zou, M.-H. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.036 · Cited by 149
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis
Ren, L.-L., Miao, H., Wang, Y.-N., Liu, F., Li, P., & Zhao, Y.-Y. (2023) · Aging and disease · doi:10.14336/ad.2023.0222 · Cited by 139
Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
Blokland, K. E. C., Pouwels, S. D., Schuliga, M., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 128
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 136
Cell Autonomous and non-autonomous effects of senescent cells in the skin
Demaria, M., Desprez, P. Y., Campisi, J., & Velarde, M. C. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.108 · Cited by 127
“Indeed, failure to induce senescence during wound healing causes fibrosis in the skin and liver (Jun and Lau, 2010; Kim et al., 2013; Krizhanovsky et al., 2008).”
BackgroundYu, O. M., & Brown, J. H. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.097857 · Cited by 127
“Other studies using vascular smooth muscle cells confirmed that S1P induced CCN1 through AP-1, and showed that this occurred through RhoA and G12/13 but not Gq or Gi signaling (Kim et al., 2011).”
BackgroundSimvastatin suppresses breast cancer cell proliferation induced by senescent cells
Liu, S., Uppal, H., Demaria, M., Desprez, P.-Y., Campisi, J., & Kapahi, P. (2015) · Scientific Reports · doi:10.1038/srep17895 · Cited by 124
“One report showed that repression of Rac1 activity by CDK5 was required for senescent phenotypes 56 , and depletion of Rac1 inhibited CCN1-induced senescence, possibly by reducing ROS 57 .”
BackgroundModulation of hepatic stellate cells and reversibility of hepatic fibrosis
Huang, Y., Deng, X., & Liang, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.038 · Cited by 122
“Some studies have focused primarily on the link between resolution of fibrosis in senescent myofibroblasts versus injured tissues of aged mice, whereas our systematic review specifically address the capacity for resolution of induction of HSC senescence [65,67].”
BackgroundHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Weiskirchen, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00303 · Cited by 112
CCN1 induces hepatic ductular reaction through integrin αvβ5–mediated activation of NF-κB
Kim, K.-H., Chen, C.-C., Alpini, G., & Lau, L. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79327 · Cited by 109
Self-citationTo clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2018) · F1000Research · doi:10.12688/f1000research.14841.1 · Cited by 104
Borkham-Kamphorst, E., Schaffrath, C., Van de Leur, E., Haas, U., Tihaa, L., Meurer, S. K., Nevzorova, Y. A., Liedtke, C., & Weiskirchen, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.023 · Cited by 105
Tripathi, U., Misra, A., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111548 · Cited by 104
“…factors, matrix metalloproteinases, growth factors, Senescence appears to be a programmed process that can contribute to tissue homeostasis and such physiological functions as embryonic and fetal development [13], parturition [14], tumor suppression [15], wound healing [16], and tissue repair [17].”
Panebianco, C., Oben, J. A., Vinciguerra, M., & Pazienza, V. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0438-x · Cited by 111
“carbon tetrachloride (CCl4) exhibit a more pronounced liver fibrosis and a decreased number of senescent cells, as judged on the basis of the expression of the SA-b-Gal marker, when compared to control mice [53].”
BackgroundInfluentialMelatonin application in targeting oxidative‐induced liver injuries: A review
Mortezaee, K., & Khanlarkhani, N. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26209 · Cited by 102
“These findings indicate that targeting ROS production in HSCs as liver fibrosis therapy may be most useful when fibrogenesis is actively in progress, but it may impede regression of fibrosis during resolution via promotion of myofibroblast senescence (Kim et al., 2013).”
BackgroundCellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
“…et al. 2005; Chen et al. 2005; Michaloglou et al. 2005; Collado et al. 2005), wound healing (Krizhanovsky et al. 2008; Jun et al. 2010; Fitzner et al. 2012; Kim et al. 2013; Demaria et al. 2014) and possibly placental development (Chuprin et al. 2013; Rajagopalan and Long 2012; Zhang et al. 2014).”
BackgroundMatricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking
Emre, Y., & Imhof, B. A. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0420-1 · Cited by 102
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 100
Faggioli, F., Palagano, E., Di Tommaso, L., Donadon, M., Marrella, V., Recordati, C., Mantero, S., Villa, A., Vezzoni, P., & Cassani, B. (2018) · Hepatology · doi:10.1002/hep.29636 · Cited by 90
“In liver injury, the hepatocyte-derived matricellular protein, CCN1, is critical for induction of HSC senescence, through a RAC/NADPH oxidase 1–dependent pathway.((22)) A significant increase in Ccn1 tissue expression was observed in Dko, compared to Mdr2,mice (Fig.”
BackgroundHuang, Y.-H., Chen, M.-H., Guo, Q.-L., Chen, Z.-X., Chen, Q.-D., & Wang, X.-Z. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109445 · Cited by 90
The matricellular protein CCN1 in tissue injury repair
Kim, K., Won, J. H., Cheng, N., & Lau, L. F. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0450-x · Cited by 91
Self-citationSenescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2
Cheng, N., Kim, K.-H., & Lau, L. F. (2022) · JCI Insight · doi:10.1172/jci.insight.158207 · Cited by 87
“In the liver, recent studies have found that cellular senescence in parenchymal cells can be detrimental to regeneration (19, 20), but senescence in hepatic stellate cells (HSCs) may limit and reduce fibrosis (21, 22).”
InfluentialSelf-citationKurundkar, A., Kurundkar, D., Rangarajan, S., Locy, M. L., Zhou, Y., Liu, R.-M., Zmijewski, J. W., & Thannickal, V. J. (2016) · The FASEB Journal · doi:10.1096/fj.201500173 · Cited by 87
“(12), CCN1 as a critical factor in terminating the wound healing process by mediating fibroblast senescence.”
BackgroundThe role of cellular senescence in tissue repair and regeneration
Antelo-Iglesias, L., Picallos-Rabina, P., Estévez‐Souto, V., Silva‐Álvarez, S. D., & Collado, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111528 · Cited by 86
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
“A similar role for senescence in tissue repair andwound healing has been shown in other tissue damage models: the liver (Kong et al. 2012; Kim et al. 2013; Borkham-Kamphorst et al. 2014), kidney (Wolstein et al. 2010), skin (Jun and Lau 2010b; Pitiyage et al. 2011; Demaria et al. 2014), and heart…”
BackgroundNADPH Oxidases in Chronic Liver Diseases
Jiang, J. X., & Torok, N. J. (2014) · Advances in Hepatology · doi:10.1155/2014/742931 · Cited by 82
Autophagy, tissue repair, and fibrosis: a delicate balance
Migneault, F., & Hébert, M. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.01.003 · Cited by 80
Mavrogonatou, E., Papadopoulou, A., Pratsinis, H., & Kletsas, D. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00178.2023 · Cited by 66
Cui, S., Xue, L., Yang, F., Dai, S., Han, Z., Liu, K., Liu, B., Yuan, Q., Cui, Z., Zhang, Y., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009111 · Cited by 72
“CCN family member 1 (CCN1, also known as CYR61) is an important component of SASP and can restrict pathological fibrosis in liver and wound healing.(13,14) In the heart, ischemia/reperfusion induces CCN1 expression in cardiomyocytes, serving as an autocrine function to mediate the cardioprotective effects.”
BackgroundResultYan, L., Lee, S., Lazzaro, D. R., Aranda, J., Grant, M. B., & Chaqour, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646950 · Cited by 73
“Generation of CCN1 mice was described previously (24).”
BackgroundMethodCellular senescence in lymphoid organs and immunosenescence
Budamagunta, V., Foster, T. C., & Zhou, D. (2021) · Aging · doi:10.18632/aging.203405 · Cited by 67
Tsou, P., Wren, J. D., Amin, M. A., Schiopu, E., Fox, D. A., Khanna, D., & Sawalha, A. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39828 · Cited by 73
“We postulate that the antifibrotic nature of this molecule should also play a significant role in inhibiting the fibrotic process in SSc, since it has been shown that CYR61 restricted fibrosis in several models of fibrosis, including the skin (28,30,31).”
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review
Mortezaee, K. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3351 · Cited by 72
“Rac1‐ NOX1‐ROS axis is an inducer of this process.(63) Progression of fibrosis is applicable when low levels of ROS exist in the HSCs.”
BackgroundStochastic non-enzymatic modification of long-lived macromolecules - A missing hallmark of aging
Fedintsev, A., & Moskalev, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101097 · Cited by 72
“Although there are different points of view, what is the cause and what is the consequence in fibrosis, and, in fact, cellular senescence might limit fibrosis (Kim et al., 2013; Krizhanovsky et al., 2008; Borkham-Kamphorst et al., 2014; Jun and Lau, 2010a) by stopping the proliferation of myofibroblasts and by secreti…”
The CCN family acting throughout the body: recent research developments
Kubota, S., & Takigawa, M. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2013-0018 · Cited by 73
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 76
“For example, cellular senescence can reduce liver fibrosis [201], promote tissue repair and has a role in not only physiological, but also pathophysiological processes (e.”
BackgroundCCN2 induces cellular senescence in fibroblasts
Jun, J.-I., & Lau, L. F. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0359-1 · Cited by 68
Self-citationAerobic exercise training in the treatment of non‐alcoholic fatty liver disease related fibrosis
Linden, M. A., Sheldon, R. D., Meers, G. M., Ortinau, L. C., Morris, E. M., Booth, F. W., Kanaley, J. A., Vieira‐Potter, V. J., Sowers, J. R., Ibdah, J. A., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272235 · Cited by 68
“2005) or the injection of CCN1 (Kim et al. 2013) was associated with increased gelatinase expression/activity and decreased TIMP-1 expression.”
BackgroundInfluentialThe matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6
Choi, J. S., Kim, K.-H., & Lau, L. F. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.19 · Cited by 62
“For example, in skin wound healing and in chronic inflammatory hepatic injuries that induce liver fibrosis, CCN1 functions to dampen fibrosis by acting through integrin a6b1 to induce cellular senescence and expression of the antifibrotic senescence-associated secretory phenotype in myofibroblasts.(16,17) In experimen…”
Self-citationQin, Z., Robichaud, P., He, T., Fisher, G. J., Voorhees, J. J., & Quan, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115402 · Cited by 64
“Abnormal regulation of CCN1 protein expression has been observed in various diseases, including wound healing and fibrosis [33, 34].”
BackgroundMerkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 71
“in vivo in the context of liver and skin injury, promoting liver regeneration and limiting fibrosis in mouse models.(52,57) In addition, the”
Induction of Fibroblast Senescence During Mouse Corneal Wound Healing
Wang, X., Qu, M., Li, J., Danielson, P., Yang, L., & Zhou, Q. (2019) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.19-26983 · Cited by 58
Cellular senescence and acute kidney injury
Lin, X., Jin, H., Chai, Y., & Shou, S. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05532-2 · Cited by 63
CCN1 interacts with integrins to regulate intestinal stem cell proliferation and differentiation
Won, J. H., Choi, J. S., & Jun, J.-I. (2022) · Nature Communications · doi:10.1038/s41467-022-30851-1 · Cited by 65
Fibroblast—Extracellular Matrix Interactions in Tissue Fibrosis
Frangogiannis, N. G. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0099-1 · Cited by 66
da Silva, B. D. O., Ramos, L. F., & Moraes, K. C. M. (2017) · Cell Biology International · doi:10.1002/cbin.10790 · Cited by 64
“…CCN (cysteine-rich 61—Cyr61/CTGF/NOV) family, is highly accumulated in cirrhotic livers and triggers senescence by the production of reactive oxygen species through the RAC1-NADPH oxidase 1 enzyme complex, which initiates the fibrosis resolution (Kim et al., 2013; Borkham-Kamphorst et al., 2016).”
BackgroundSenescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 64
“However, when senescence is induced in myofibroblasts or in hepatic stellate cells, which are mesenchymal cells involved in healing by acquiring a fibroblastlike phenotype upon injury, the effect can be beneficial by limiting fibrosis [33, 53].”
BackgroundCellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Hypoxia-induced Deoxycytidine Kinase Contributes to Epithelial Proliferation in Pulmonary Fibrosis
Weng, T., Poth, J. M., Karmouty‐Quintana, H., Garcia‐Morales, L. J., Melicoff, E., Luo, F., Chen, N., Evans, C. M., Bunge, R. R., Bruckner, B. A., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0744oc · Cited by 61
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 62
“fibrosis [186,257,258] with some studies suggesting a pro-inflammatory role of this protein and”
BackgroundAntifibrotics in chronic liver disease: tractable targets and translational challenges
Ramachandran, P., & Henderson, N. C. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30110-8 · Cited by 50
CCN1/CYR61 overexpression in hepatic stellate cells induces ER stress-related apoptosis
Borkham-Kamphorst, E., Steffen, B. T., Van de Leur, E., Haas, U., Tihaa, L., Friedman, S. L., & Weiskirchen, R. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.013 · Cited by 55
“Adenovirus mediated overexpression of CCN1 in portal myofibroblasts (pMF) induces cellular apoptosis rather than senescence [19], while CCN1 protein induces cellular senescence resulting in attenuation of liver fibrosis in experimental cholestatic- and hepatotoxicinduced liver injuries [20].”
Lu, Y., Wen, H., Liu, C., Wang, C., Yu, H., Zhang, K., Han, Q., Liu, Y., Han, Z., Li, Z., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.011 · Cited by 63
Chintala, H., Krupska, I., Yan, L., Lau, L., Grant, M., & Chaqour, B. (2015) · Development · doi:10.1242/dev.121913 · Cited by 52
“Recombination levels in iΔEC−/− mice as compared with CCN1 were determined as described previously (Kim et al., 2013).”
MethodSelf-citationPremature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation
Xie, J., Chen, Y., Hu, C., Pan, Q., Wang, B., Li, X., Geng, J., & Xu, B. (2017) · Oncotarget · doi:10.18632/oncotarget.19853 · Cited by 52
“Based on the findings of pro-senescent treatments that can reverse the skin and liver fibrosis [20, 21], there might be a possibility that premature senescence can also restrain cardiac”
BackgroundChen, C.-C., Kim, K.-H., & Lau, L. F. (2015) · Oncogene · doi:10.1038/onc.2015.190 · Cited by 52
“Ccn1ΔHep mice were generated by intercross of Ccn1flox/flox and Alb-Cre mice (Jackson Laboratory)(10).”
BackgroundMethodSelf-citationLai, C., Lin, S., Chiang, W., Chen, Y., Wu, V., Young, G., Ko, W.-J., Kuo, M., Tsai, T., & Wu, K. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00670.2013 · Cited by 52
“Furthermore, one recent study (23) using a carbon tetrachloride liver injury model in hepatocyte-specific Cyr61 deletion mice reported that Cyr61 attenuates liver fibrosis by inducing myofibroblast senescence.”
BackgroundCellular senescence: friend or foe to respiratory viral infections?
Kelley, W. J., Zemans, R. L., & Goldstein, D. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.02708-2020 · Cited by 45
“In addition, senescent cells may upregulate phagocytic receptors, therefore increasing phagocytosis and immune surveillance to reduce cancer development.”
BackgroundRole of the Hippo pathway in liver regeneration and repair: recent advances
Pibiri, M., & Simbula, G. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00235-5 · Cited by 51
Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting
Singanayagam, A., & Triantafyllou, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661182 · Cited by 48
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Emerging role of CCN family proteins in fibrosis
Sun, C., Zhang, H., & Liu, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30171 · Cited by 47
“N‐terminal kinase (JNK) and p38 MAPK that promote apoptosis (Borkham‐Kamphorst, Steffen, Van de Leur, Haas, et al., 2016; Borkham‐Kamphorst, Steffen, Van de Leur, Tihaa, 2016; Borkham‐Kamphorst et al., 2018).”
BackgroundInfluentialAging, senescence, and cutaneous wound healing—a complex relationship
O’Reilly, S., Markiewicz, E., & Idowu, O. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429716 · Cited by 48
The Role of Ageing and Parenchymal Senescence on Macrophage Function and Fibrosis
Campbell, R., Docherty, M.-H., Ferenbach, D. A., & Mylonas, K. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700790 · Cited by 47
“However, this has also been shown to activate DNA damage response (DDR) pathways and p53 by engaging integrin a6b1 which generates the production of reactive oxygen species (ROS) which stimulates the DDR, activating the p53-p21 dependent pathway of cellular senescence (32, 55, 56).”
Background
Metadata
- Authors
- Kim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F.
- Affiliations
- Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois, USA
- University of Illinois Chicago (US)
- ORCID
- Lau, Lester F.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-05-01
- Volume
- 33
- Issue
- 10
- Pages
- 2078-2090
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3647960
- OpenAlex
- W2160370983
- Cited by
- 261
- References
- 57
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 10 · 2023: 17 · 2022: 18 · 2021: 26 · 2020: 24 · 2019: 17 · 2018: 20 · 2017: 27 · 2016: 27 · 2015: 23 · 2014: 24 · 2013: 6
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM078492, GM78492)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR061791, AR61791)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- CYR61, liver fibrosis, fibrosis regression, cellular senescence, hepatic stellate cells, portal fibroblasts, alpha6beta1 integrin, Rac1, NOX1, reactive oxygen species, CCN family, hepatocyte-specific deletion, carbon tetrachloride, bile duct ligation, liver cirrhosis, antifibrotic therapy
- MeSH terms
- NADPH Oxidase 1, Animals, Binding Sites, Carbon Tetrachloride, Cells, Cultured, Cholestasis, Female, Humans, Liver, Liver Cirrhosis, Male, Mice, Inbred C57BL, Mice, Transgenic, NADH, NADPH Oxidoreductases, Neuropeptides, Signal Transduction, Cellular Senescence, Reactive Oxygen Species, rac GTP-Binding Proteins, rac1 GTP-Binding Protein, Integrin alpha6beta1, Tissue Array Analysis, Mice, Hepatic Stellate Cells, Cysteine-Rich Protein 61, Mice, 129 Strain, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.